Form 4: Regis director granted 2,727 shares

Regis Corp director Nancy C. Benacci received 2,727 common shares on Nov 14, 2025 at no cost, vesting by the earlier of Nov 14, 2026 or the next annual meeting.

Summary

• Nancy C. Benacci, a director of Regis Corp (RGS), acquired 2,727 common shares on 11/14/2025 via an equity award at $0 per share (code: A).
• Post-transaction, Benacci directly beneficially owns 5,927 shares.
• The award vests on the earlier of 11/14/2026 or the next annual meeting of shareholders after 11/14/2025, subject to continued service and grant terms.
• No derivative securities were reported.
• The transaction was reported with a signature date of 11/18/2025.

Sentiment

Score: 5

Explanation: Routine director equity grant that modestly aligns interests; neutral impact on fundamentals and valuation.

Positives

• Equity grant aligns director incentives with shareholder interests.
• No cash outlay ($0 grant price) and minimal dilution given small share count (2,727 shares).
• Straightforward, time-based vesting schedule typical for board compensation, reinforcing retention through the next annual meeting.

Negatives

• Incremental dilution from new shares, albeit immaterial at 2,727 shares.
• No operational, financial, or strategic performance information provided.

Risks

• Vesting is contingent on continued service through the vesting date; the award may not vest if service terminates or conditions under the grant are not met.

Future Outlook

No guidance or operational outlook is provided; only the vesting timeline tied to continued service through the earlier of 11/14/2026 or the next annual meeting.

Industry Context

Annual, time-based equity awards that vest at the next shareholder meeting are standard for U.S. public company directors, especially among small- and mid-cap consumer services firms. This award structure aligns governance with market norms and emphasizes retention without introducing performance conditions.

Comparison to Industry Standards

• Award structure (time-based vesting to next annual meeting) is consistent with director equity programs at peers such as Ulta Beauty (ULTA), Sally Beauty (SBH), and Petco (WOOF), which commonly grant annual RSUs/stock awards to directors with one-year vesting tied to the next shareholder meeting.
• A zero-cost equity grant is standard for director compensation equity (RSUs or restricted stock) across U.S. listings; purchase plans or options are less common for non-employee directors.
• The absolute share count (2,727) suggests a modest-sized award typical of micro/small-cap companies, with the effective dollar value depending on prevailing share price rather than fixed share counts used at large caps.

Related Party Transactions

• Director equity grant: 2,727 common shares at $0 to Nancy C. Benacci on 11/14/2025; beneficial ownership after the transaction is 5,927 shares (direct).

Stakeholder Impact

• Shareholders: negligible dilution; improved director-shareholder alignment.
• Employees and customers: no direct impact.
• Creditors: no impact on credit profile or cash flows.

Next Steps

• Equity award to vest on the earlier of 11/14/2026 or the next annual meeting after 11/14/2025, contingent on continued service.

Key Dates

Keywords

Regis Corp, RGS, insider transaction, Form 4, director stock grant, restricted stock award, equity compensation, beneficial ownership, board of directors, vesting schedule